Abstract
Background
The aim of this study was to characterize patterns of multimorbidity across patients and identify opportunities to strengthen the informatics capacity of learning health systems that are used to characterize multimorbidity across patients.
Methods
Electronic health record (EHR) data on 225,710 multimorbidity patients were extracted from the Arkansas Clinical Data Repository as a use case. Hierarchical cluster analysis identified the most frequently occurring combinations of chronic conditions within the learning health system’s captured data.
Results
Results revealed multimorbidity was highest among patients ages 60 to 74, Caucasians, females, and Medicare payors. The largest numbers of chronic conditions occurred in the smallest numbers of patients (i.e., 70,262 (31%) patients with two conditions, two (<1%) patients with 22 chronic conditions). The results revealed urgent needs to improve EHR systems and processes that collect and manage multimorbidity data (e.g., creating new, multimorbidity-centric data elements in EHR systems, detailed longitudinal tracking of compounding disease diagnoses).
Conclusions
Without additional capacity to collect and aggregate large-scale data, multimorbidity patients cannot benefit from the recent advancements in informatics (i.e., clinical data registries, emerging data standards) that are abundantly working to improve the outcomes of patients with single chronic conditions. Additionally, robust socio-technical system studies of clinical workflows are needed to assess the feasibility of integrating the collection of risk factor data elements (i.e., psycho-social, cultural, ethnic, and socioeconomic attributes of populations) into primary care encounters. These approaches to advancing learning health systems for multimorbidity could substantially reduce the constraints of current technologies, data, and data-capturing processes.
Keywords: multimorbidity, electronic health record, informatics, learning health system, patterns
Introduction
Individuals living with two or more chronic conditions (i.e., multimorbidity) face substantial health challenges that require ongoing medical attention and limit activities of daily living.1–9 Multimorbidity is associated with higher mortality rates, worsened functional status, and diminished quality of life when compared to those who have one or no chronic conditions.2–4 Nationally, 81% of Americans ages 65 and older have multimorbidity.4,5 However, multimorbidity is expanding beyond its traditional associations with elderly and aging populations, with 50% of Americans ages 45 to 65 having multiple chronic conditions.5–13
Arkansas has been ranked as having the second-highest multimorbidity prevalence of all 50 states in adults ages 18–45, 5 reflecting the substantial burden of multimorbidity on healthcare systems. Yet, patterns of how multimorbidity is occurring among populations remain underexamined at national and more localized levels, restricting what is known about multimorbidity to focus on estimating the dyads and triads of the most frequently combinations of chronic conditions in Arkansas. Consequently, attempts at elucidating how multimorbidity is occurring have been heavily constrained by the lack of integrated technologies and opportunities for data aggregation that exists within the domain of biomedical informatics.13–25 Examining the capacities of the learning health systems (LHS) and processes in which multimorbidity data are collected and managed has not been prioritized,14–30 leaving much of what is known about multimorbidity to focus on simply revealing patterns of chronic conditions among elderly patients (i.e., ages ≥65). Therefore, the aim of this study was to 1) characterize patterns of multimorbidity across patients, more broadly, among all demographic groups (i.e., age, gender, race, and ethnicity) and 2) concurrently, identify opportunities to strengthen the informatics capacity (i.e., technologies, data, and processes) of a learning health system, using the Arkansas Clinical Data Repository as a use case. More specifically, the study was guided by the following research questions: 1) what are the patterns of multimorbidity across patients, stratified by age, gender, race, and ethnicity and 2) what opportunities exist to strengthen the informatics capacity of learning health systems that are used to characterize patterns of multimorbidity across patients?
The characterization of multimorbidity in learning health systems
Learning health systems are data-driven, healthcare delivery processes of continuous quality improvement, providing patients with higher quality, safer, and more effective care by utilizing informatics and data science to translate research into evidence-based practice.31,32 However, opportunities to improve multimorbidity patient outcomes are widely constrained by the current informatics infrastructure that is used to characterize the outcomes of patients with multimorbidity.2,4,6,31–35 To date, these informatics constraints have included the subjectivity (i.e., recall bias) of analyzing self-reported data gathered through national databases (i.e., National Health Interview Survey) and the focus on specific sets of chronic conditions versus all combinations that could potentially encompass multimorbidity (i.e., Behavioral Risk Factor Surveillance System Surveys).2,6 Additionally, the exclusion of institutionalized adults (long-term care settings, correctional facilities, etc.) has been a significant constraint of using national databases to examine multimorbidity, leading to the underreporting of chronic conditions. 4 However, the informatics capacity within learning health systems can be improved to address the siloed and fragmented clinical data which constrains the sharing of knowledge that supports improvements in the care outcomes of patients with multimorbidity.
Methods
Ethics declaration statement
The study protocol (#262593) was reviewed and approved by the Institutional Review Board at the University of Arkansas for Medical Sciences (UAMS).
Study design and participants
As a retrospective, cross-sectional study, electronic medical record (EMR) data were extracted from the Arkansas Clinical Data Repository (AR-CDR) in Little Rock, AR. The AR-CDR’s data warehouse contains longitudinal data, regularly imported from the UAMS EHR, which collects data from encounters with patients throughout Arkansas. The AR-CDR is a comprehensive resource containing patient information (i.e., demographics, diagnoses, charges, and laboratory data). 33 Within the AR-CDR, data are de-identified, cleaned, transformed, and stored. The AR-CDR, supported by a Clinical and Translational Science Award, has facilitated advances in medical research through the effective recruitment of research subjects and supports secondary use of clinical data. 33 The AR-CDR is the core of the University of Arkansas for Medical Sciences’ Learning Health System (UAMS LHS), utilizing informatics, data, and evidence-based practice to improve care quality, safety, and efficiency.31–35
Inclusion criteria used to identify patient records in this study were 1) a diagnosis of two or more chronic conditions through at least one primary care encounter between 1 January 2014, and 1 July 2021, and 2) an age of 18 years or older. Patients who were under the age of 18 at any time during the study period were excluded. Race, ethnicity, gender, socioeconomic, and insurance status were not used as inclusion criteria.
Multimorbidity and chronic condition selection
Chronic conditions were identified using the International Classification of Diseases Rv.10 (ICD-10) codes and limited to the Centers for Medicare and Medicaid’s formally recognized list of chronic conditions. 1 To obtain a comprehensive view of all potential patterns occurring within the multimorbidity population, 29 ICD-10 codes identified the following conditions: AIDS; alcohol abuse; anemia deficiency; blood loss anemia; cardiac arrhythmias; chronic pulmonary disease; coagulopathy; congestive heart failure; depression; diabetes, complicated; diabetes, uncomplicated; drug abuse; fluid and electrolyte disorders; hypertension, complicated; hypothyroidism; liver disease; lymphoma; metastatic cancer; neurological disorders; obesity; paralysis; peripheral vascular disorders; peptic ulcer disease; psychoses; pulmonary circulation disorders; renal failure; rheumatoid arthritis and collagen vascular diseases; solid tumor without metastasis; and valvular disease.
Data collection and analysis
Discrete variables of interest were gender, race, ethnicity, insurance provider type, and chronic condition diagnoses (i.e., ICD-10 codes). Age intervals were constructed based on gaps and recommendations for better categorizing multimorbidity across patients.4–7,14–18 Age (i.e., 18–105), the only continuous variable, was examined by intervals (i.e., 18–30, 31–44, 45–59, 60–74, 75–88, and 89–105). Upon extraction of data from the AR-CDR, all variables were cleaned (i.e., removing duplicates, missing data) using Google Open Refine 2.0. Descriptive statistics (means, medians, modes, and frequencies) were calculated using IBM SPSS V.27 to characterize demographic variables. To provide a more robust identification of multimorbidity characteristics, descriptive statistics were stratified by three groups (i.e., patients with two chronic conditions, patients with three chronic conditions, and patients with four or more chronic conditions). Google Open Refine 2.0 was also used to perform hierarchical cluster analysis, identifying the top five most frequently occurring combinations of chronic conditions: stratified by age, race, ethnicity, and insurance payor.
Results
Data extraction identified an overall study population of 225,710 patients who met the study’s inclusion criteria. Figure 1 reflects the number of chronic conditions of multimorbidity patients in the total study sample. The patterns of chronic conditions within each patient generally occurred in smaller numbers (circled). For example, there were 70,262 (31%) patients with multimorbidity in the population that had only two chronic conditions as opposed to two (<1%) patients with 22 chronic conditions.
Figure 1.
Number of patients with multimorbidity by the number of chronic conditions.
When further stratified by the number of total chronic conditions, there were 152,710 (67.7%) multimorbidity patients with three chronic conditions and 105,659 (46.8%) multimorbidity patients with four or more chronic conditions. Table 1 provides study demographics, stratified by the total number of chronic conditions. Multimorbidity patients with two chronic conditions had a mean age of 56.87 and a SD of 18.13, as compared to a mean age of 58.87 and an SD of 17.48 for multimorbidity patients with three chronic conditions. Multimorbidity patients with four or more chronic conditions had a mean age of 60.44 and an SD of 16.81. Median ages for each group were 59, 61, and 62 for patients with two, three, or four or more chronic conditions, respectively. In terms of age, patients ages 60 to 74 had the highest percentage of multiple chronic conditions with 30%, 32%, and 34% having two, three, or four or more chronic conditions, respectively. Although patients ages 89 to 105 had the lowest percentage of multiple chronic conditions with 3%, 4%, and 4% of patients with two, three, or four or more chronic conditions, respectively.
Table 1.
Demographics stratified by number of conditions.
| Patient demographic variables | Two chronic conditions [n = 221,792] | Three chronic conditions [n = 152,710] | Four or more chronic conditions [n = 105,659] |
|---|---|---|---|
| Number of conditions, mean (range) | 4.19 (2–22) | 5.18 (3–22) | 6.16 (4–22) |
| Age, mean | 56.87 | 58.87 | 60.44 |
| Age, median | 59 | 61 | 62 |
| Age, mode | 89 | 89 | 89 |
| Age, range | 18–105 | 18–105 | 18–105 |
| Age, standard deviation (SD) | 18.13 | 17.48 | 16.81 |
| Age intervals, years (%) | |||
| 18–30 | 21722 (0.1) | 11165 (0.07) | 5775 (0.05) |
| 31–44 | 39350 (0.18) | 23908 (0.16) | 14675 (0.14) |
| 45–59 | 54118 (0.24) | 37794 (0.25) | 26264 (0.25) |
| 60–74 | 66282 (0.30) | 48909 (0.32) | 35967 (0.34) |
| 75–88 | 32924 (0.15) | 25135 (0.16) | 18596 (0.18) |
| 89–105 | 7396 (0.03) | 5799 (0.04) | 4382 (0.04) |
| Race, number (%) | |||
| Caucasian American | 138387 (0.62) | 95770 (0.63) | 66307 (0.63) |
| African American/Black | 61776 (0.28) | 44296 (0.29) | 31747 (0.30) |
| Asian American | 1308 (<0.00) | 798 (<0.00) | 507 (<0.00) |
| American Indian/Alaskan Native | 702 (<0.00) | 499 (<0.00) | 373 (<0.00) |
| Native Hawaiian/Other Pacific Islander | 611 (<0.00) | 380 (<0.00) | 204 (<0.00) |
| Other race | 6965 (0.03) | 4150 (0.03) | 2667 (0.03) |
| Unknown race | 12043 (0.05) | 6816 (0.04) | 3853 (0.04) |
| Ethnicity, number (%) | |||
| Hispanic/LatinX/Spanish | 6401 (0.03) | 3627 (0.02) | 2246 (0.02) |
| Gender | |||
| Male | 88683 (0.4) | 61053 (0.4) | 42412 (0.4) |
| Female | 133075 (0.6) | 91642 (0.6) | 63239 (0.6) |
| Unknown | 34 (<0.00) | 15 (0.000) | 8 (0.000) |
| Insurance payor, number (%) | |||
| Medicare | 80795 (0.36) | 63305 (0.41) | 48443 (0.46) |
| Medicaid | 34040 (0.15) | 23405 (0.15) | 15927 (0.15) |
| Blue cross Blue Shield | 40154 (0.18) | 25412 (0.17) | 16354 (0.15) |
| Private insurance | 40864 (0.18) | 25546 (0.17) | 16298 (0.15) |
| Unknown insurance | 25939 (0.12) | 15042 (0.10) | 8637 (0.08) |
Table 1 reflects several patterns of multimorbidity across patients. First, the total number of chronic conditions increased among patients over time between ages 18 to 74, but were smaller in number (7396) among those that were 89 years or older. Second, Caucasian Americans were the largest racial group within the total study population with multimorbidity accounting for 62%, 63%, and 63% of patients that had two, three, or four or more chronic conditions, respectively. African Americans, as the second largest group with multimorbidity, had 28%, 29%, and 30% of patients with two, three, and four or more chronic conditions, respectively. Third, female patients accounted for 60%, and males accounted for 40% of all patients with multimorbidity. Finally, within insurance providers, Medicare was the primary payor for 36%, 41%, and 46% of patients with multimorbidity that had two, three, or four or more chronic conditions, respectively.
Hierarchical cluster analysis and multimorbidity combinations
Hierarchical cluster analysis identified 53,288 combinations of chronic conditions that existed within the overall study population of 225,710 patients with multimorbidity who had two chronic conditions. Tables 2–4 present the top five most frequently occurring combinations of chronic conditions that were identified, stratified by age and gender (Table 2), age and race (Table 3), and age and ethnicity (Table 4).
Table 2.
Most frequent combinations of chronic conditions stratified by age and gender.
| Age range | Male | Female | ||
|---|---|---|---|---|
| All ages (%) [n = 221792] | 88683 (0.4) | 133075 (0.6) | ||
| 1 | DM + HTN | 3267 (0.04) | HTN + OB | 3788 (0.03) |
| 2 | HTN + OB | 2180 (0.02) | DM + HTN | 3245 (0.02) |
| 3 | DP + PSY | 1416 (0.02) | DP + PSY | 2866 (0.02) |
| 4 | HTN + NEU | 1177 (0.01) | DP + HTN | 1949 (0.01) |
| 5 | HTN + TU | 1070 (0.01) | DP + OB | 1106 (0.01) |
| 18–30, (0.10) [n = 21722] | 5982 (0.28) | 15737 (0.72) | ||
| 1 | DP + PSY | 678 (0.11) | DP + PSY | 1182 (0.08) |
| 2 | HTN + OB | 151 (0.03) | ANE + BL | 549 (0.03) |
| 3 | CP + OB | 135 (0.02) | DP + OB | 514 (0.03) |
| 4 | DP + DG + PSY | 133 (0.02) | HTN + OB | 486 (0.03) |
| 5 | DG + PSY | 130 (0.02) | DP + OB + PSY | 305 (0.02) |
| 31–44, (0.18) [n = 39350] | 12786 (0.32) | 26557 (0.68) | ||
| 1 | HTN + OB | 502 (0.04) | HTN + OB | 1182 (0.04) |
| 2 | DP + PSY | 414 (0.03) | DP + PSY | 848 (0.03) |
| 3 | DM + HTN | 217 (0.02) | DP + OB | 592 (0.02) |
| 4 | DG + PSY | 210 (0.02) | ANE + BL | 418 (0.02) |
| DP + HTN | 192 (0.01) | DP + HTN | 415 (0.02) | |
| 45–59, (0.24) [n = 54118] | 22909 (0.42) | 31203 (0.58) | ||
| 1 | DM + HTN | 999 (0.04) | HTN + OB | 1104 (0.04) |
| 2 | HTN + OB | 790 (0.03) | DM + HTN | 816 (0.03) |
| 3 | DM + DMC + HTN | 324 (0.01) | DP + HTN | 603 (0.02) |
| 4 | DP + HTN | 321 (0.01) | DP + PSY | 447 (0.01) |
| 5 | DM + HTN + OB | 310 (0.01) | DP + HTN + OB | 310 (0.01) |
| 60–74, (0.30) [n = 66282] | 30262 (0.46) | 36014 (0.54) | ||
| 1 | DM + HTN | 1400 (0.05) | DM + HTN | 1342 (0.04) |
| 2 | HTN + OB | 643 (0.02) | HTN + OB | 857 (0.02) |
| 3 | HTN + TU | 530 (0.02) | DP + HTN | 616 (0.02) |
| 4 | DM + DMC + HTN | 371 (0.01) | HTN + HY | 470 (0.01) |
| 5 | HTN + NEU | 335 (0.01) | HTN + TU | 392 (0.01) |
| 75–88, (0.15) [n = 32924] | 14397 (0.44) | 18523 (0.56) | ||
| 1 | DM + HTN | 579 (0.04) | DM + HTN | 615 (0.03) |
| 2 | HTN + TU | 329 (0.02) | HTN + HY | 328 (0.02) |
| 3 | HTN + NEU | 319 (0.02) | HTN + NEU | 321 (0.02) |
| 4 | DM + DMC + HTN | 150 (0.01) | HTN + TU | 298 (0.2) |
| 5 | HTN + PER | 145 (0.01) | DP + HTN | 169 (0.01) |
| 89–105, (0.03) [n = 7396] | 2347 (0.32) | 5041 (0.68) | ||
| 1 | HTN + NEU | 64 (0.03) | HTN + NEU | 144 (0.03) |
| 2 | DM + HTN | 43 (0.02) | HTN + HY | 111 (0.02) |
| 3 | HTN + TU | 40 (0.02) | DM + HTN | 97 (0.02) |
| 4 | CHF + HTN | 34 (0.01) | CHF + HTN | 70 (0.01) |
| 5 | METS + TU | 26 (0.01) | HTN + TU | 51 (0.01) |
*ANE = anemia deficiency; BL = blood loss anemia; CHF = congestive heart failure; CP = chronic pulmonary disease; DG = Drug abuse; DM = diabetes, uncomplicated; DMC = diabetes, complicated; DP = depression; HTN = hypertension, complicated; METS = metastatic cancer; NEU = neurological disorders; OB = obesity; PER = peripheral vascular disorders; PSY = psychoses; TU = solid tumor without metastasis. **Participants with unknown gender were excluded from this table because they represented less than 1% (n = 34) of the study population.
Table 4.
Most frequent combinations of chronic conditions stratified by age, unknown race, and ethnicity.
| Rank | Other race | Unknown race | Ethnicity, Hispanic/LatinX/Spanish | |||
|---|---|---|---|---|---|---|
| All ages, number (%), [n = 221792] | ||||||
| 6965 (0.03) | 12043 (0.05) | 6410 (0.03) | ||||
| 1 | DM + HTN | 263 (0.04) | DP + PSY | 508 (0.04) | DM + HTN | 248 (0.04) |
| 2 | ANE + BL | 250 (0.04) | DM + HTN | 460 (0.04) | ANE + BL | 230 (0.04) |
| 3 | HTN + OB | 178 (0.03) | HTN + OB | 378 (0.03) | HTN + OB | 197 (0.03) |
| 4 | DP + PSY | 151 (0.02) | CP + HTN | 230 (0.02) | DP + PSY | 193 (0.03) |
| 5 | DM + OB | 82 (0.01) | DP + HTN | 228 (0.02) | DM + OB | 99 (0.02) |
| Ages: 18–30, (0.10) [n = 21722] | ||||||
| 1387 (0.06) | 1846 (0.08) | 1525 (0.05) | ||||
| 1 | ANE + BL | 138 (0.1) | DP + PSY | 269 (0.15) | ANE + BL | 134 (0.09) |
| 2 | DP + PSY | 83 (0.06) | CP + DP | 96 (0.05) | DP + PSY | 123 (0.08) |
| 3 | ANE + BL + OB | 33 (0.02) | HTN + OB | 62 (0.03) | DP + OB | 46 (0.03) |
| 4 | DP + OB | 33 (0.02) | DP + OB | 61 (0.03) | HTN + OB | 41 (0.03) |
| 5 | HTN + OB | 31 (0.02) | CP + OB | 42 (0.03) | BL + OB | 35 (0.02) |
| Ages: 31–44, (0.18) [n = 39350] | ||||||
| 2045 (0.05) | 2015 (0.05) | 1989 (0.05) | ||||
| 1 | ANE + BL | 112 (0.05) | DP + PSY | 145 (0.07) | ANE + BL | 96 (0.05) |
| 2 | HTN + OB | 72 (0.04) | HTN + OB | 104 (0.05) | HTN + OB | 82 (0.04) |
| 3 | DM + OB | 50 (0.03) | DP + OB | 58 (0.03) | DM + OB | 57 (0.03) |
| 4 | DM + HTN | 47 (0.03) | DP + HTN | 51 (0.03) | DP + PSY | 47 (0.02) |
| 5 | DP + PSY | 43 (0.03) | DM + HTN | 51 (0.03) | DM + HTN | 46 (0.02) |
| Ages: 45–59, (0.24), [n = 54118] | ||||||
| 1664 (0.03) | 2670 (0.05) | 1520 (0.03) | ||||
| 1 | DM + HTN | 106 (0.06) | HTN + OB | 130 (0.05) | DM + HTN | 108 (0.07) |
| 2 | HTN + OB | 51 (0.03) | DM + HTN | 114 (0.04) | HTN + OB | 52 (0.03) |
| 3 | DM + DMC | 26 (0.02) | DP + HTN | 93 (0.03) | DM + DMC + HTN | 42 (0.02) |
| 4 | DM + DMC + HTN | 24 (0.01) | DP + PSY | 60 (0.02) | DM + DMC | 29 (0.03) |
| 5 | DP + HTN | 20 (0.01) | CP + HTN | 53 (0.02) | DP + HTN | 18 (0.01) |
| Ages: 60–74, (0.30), [n = 66282] | ||||||
| 1297 (0.02) | 3300 (0.05) | 981 (0.01) | ||||
| 1 | DM + HTN | 103 (0.06) | DM + HTN | 196 (0.06) | DM + HTN | 71 (0.07) |
| 2 | HTN + OB | 22 (0.02) | CP + HTN | 104 (0.03) | DM + DMC + HTN | 21 (0.02) |
| 3 | DM + DMC + HTN | 19 (0.01) | METS + TU | 86 (0.03) | HTN + OB | 18 (0.02) |
| 4 | DM + HTN + OB | 16 (0.01) | HTN + OB | 71 (0.02) | HTN + TU | 12 (0.01) |
| 5 | DMC + HTN | 15 (0.01) | DP + HTN | 51 (0.02) | HTN + LIV | 11 (0.01) |
| Ages: 75–88, (0.15), [n = 32924] | ||||||
| 477 (0.01) | 1697 (0.05) | 314 (0.19) | ||||
| 1 | DM + HTN | 24 (0.05) | DM + HTN | 75 (0.04) | DM + HTN | 11 (0.03) |
| 2 | HTN + HY | 8 (0.02) | METS + TU | 52 (0.03) | DM + DMC + HTN | 6 (0.02) |
| 3 | HTN + LYT | 7 (0.01) | CP + HTN | 34 (0.02) | DMC + HTN | 4 (0.01) |
| 4 | DM + DMC + HTN | 6 (0.01) | HTN + HY | 31 (0.02) | HTN + LYT | 4 (0.01) |
| 5 | HTN + PAR | 5 (0.01) | HTN + TU | 23 (0.01) | HTN + REN | 4 (0.01) |
| Ages: 89–105, (0.03), [n = 7396] | ||||||
| 95 (0.01) | 515 (0.07) | 81 (0.01) | ||||
| 1 | DM + HTN | 4 (0.04) | HTN + NEU | 16 (0.03) | DM + HTN | 2 (0.02) |
| 2 | HTN + NEU | 4 (0.04) | DM + HTN | 11 (0.02) | NEU + ULC | 1 (0.01) |
| 3 | HTN + LYT | 2 (0.02) | HTN + PER | 10 (0.02) | NEU + TU | 1 (0.01) |
| 4 | HTN + HY + LYT + NEU | 2 (0.02) | CHF + HTN | 9 (0.02) | HTN + REN | 1 (0.01) |
| 5 | ANE + COA + HTN + HY + LYT + TU | 1 (0.01) | HTN + LYT | 9 (0.02) | HTN + LYT | 1 (0.01) |
*ANE = anemia deficiency; BL = blood loss anemia; CHF = congestive heart failure; COA = coagulopathy; CP = chronic pulmonary disease; DP = depression; DM = diabetes, uncomplicated; DMC = diabetes, complicated; HTN = hypertension, complicated; HY = hypothyroidism; LIV = liver disease; LYT = fluid and electrolyte disorders; METS = metastatic cancer; NEU = neurological disorders; OB = obesity; PAR = paralysis; PER = peripheral vascular disorders; PSY = psychoses; TU = solid tumor without metastasis; ULC = peptic ulcer disease.
Table 3.
Most frequent combinations of chronic conditions stratified by age and race.
| Caucasian American | African American | Asian American | American Indian/Alaskan native | Native Hawaiian/Pacific Islander | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| All ages, number (%), [n = 221792] | ||||||||||
| 138386 (0.62) | 61776 (0.28) | 1308 (0.01) | 702 (<0.00) | 611 (<0.00) | ||||||
| 1 | DM + HTN | 3615 (0.03) | HTN + OB | 2430 (0.04) | DM + HTN | 56 (0.04) | DM + HTN | 24 (0.04) | DM + DMC + HTN | 56 (0.09) |
| 2 | HTN + OB | 2924 (0.02) | DM + HTN | 2062 (0.03) | DP + PSY | 41 (0.03) | HTN + OB | 15 (0.02) | DM + DMC | 48 (0.08) |
| 3 | DP + PSY | 2749 (0.02) | DP + PSY | 820 (0.01) | HTN + OB | 34 (0.03) | ANE + BL | 10 (0.01) | DM + HTN | 34 (0.06) |
| 4 | DP + HTN | 1566 (0.01) | DP + HTN | 593 (0.01) | ANE + BL | 23 (0.02) | DP + PSY | 10 (0.01) | DMC + HTN | 25 (0.04) |
| 5 | HTN + TU | 1425 (0.01) | DM + HTN + OB | 543 (0.01) | HTN + LIV | 16 (0.01) | DP + OB | 7 (0.01) | DM + DMC + HTN + OB | 16 (0.03) |
| Ages: 18–30, (0.10) [n = 21722] | ||||||||||
| 10354 (0.48) | 7917 (0.36) | 110 (0.01) | 72 (<0.00) | 36 (<0.00) | ||||||
| 1 | DP + PSY | 1124 (0.11) | DP + PSY | 475 (0.06) | DP + PSY | 17 (0.15) | DP + PSY | 4 (0.05) | ANE + BL | 4 (0.11) |
| 2 | HTN + OB | 255 (0.02) | HTN + OB | 284 (0.04) | DP + OB | 4 (0.04) | CP + OB | 3 (0.04) | DMC + HTN | 2 (0.05) |
| 3 | DP + OB | 254 (0.02) | ANE + BL | 252 (0.03) | HY + OB | 3 (0.03) | HTN + OB | 3 (0.04) | ANE + BL + COA + DM | 2 (0.05) |
| 4 | DP + NEU | 194 (0.02) | DP + OB | 160 (0.02) | CP + DP + PSY | 3 (0.03) | ANE + BL | 2 (0.03) | DP + PSY | 2 (0.05) |
| 5 | DP + DG | 183 (0.02) | DP + OB+ PSY | 116 (0.01) | ANE + BL | 3 (0.03) | DP + OB | 2 (0.03) | BL + OB | 2 (0.05) |
| Ages: 31–44, (0.18) [n = 39350] | ||||||||||
| 21058 (0.54) | 13611 (0.35) | 331 (0.01) | 160 (<0.00) | 131(<0.00) | ||||||
| 1 | DP + PSY | 822 (0.04) | HTN + OB | 823 (0.06) | ANE + BL | 20 (0.06) | ANE + BL | 8 (0.05) | DM + DMC | 19 (0.15) |
| 2 | HTN + OB | 668 (0.03) | DP + PSY | 229 (0.02) | DP + PSY | 17 (0.05) | DP + OB | 5 (0.03) | DM + HTN | 8 (0.06) |
| 3 | DP + NEU | 366 (0.02) | DP + HTN | 213 (0.02) | HTN + OB | 10 (0.03) | DP + PSY | 4 (0.03) | DM + OB | 6 (0.05) |
| 4 | DP + OB | 336 (0.02) | DP + OB | 190 (0.01) | HY + OB | 6 (0.02) | DM + HTN | 4 (0.03) | HTN + OB | 6 (0.05) |
| 5 | DP + HTN | 325 (0.02) | DM + HTN | 189 (0.01) | CP + DP | 5 (0.01) | HTN + LYT | 3 (0.02) | DM + DMC + OB | 5 (0.04) |
| Ages: 45–59, (0.24), [n = 54118] | ||||||||||
| 32268 (0.6) | 16736 (0.31) | 342 (0.01) | 214 (<0.00) | 223 (<0.00) | ||||||
| 1 | HTN + OB | 898 (0.03) | HTN + OB | 790 (0.05) | DM + HTN | 22 (0.06) | DM + HTN | 9 (0.04) | DM + DMC + HTN | 28 (0.13) |
| 2 | DM + HTN | 882 (0.03) | DM + HTN | 673 (0.04) | HTN + OB | 15 (0.04) | DM + HTN + OB | 4 (0.02) | DM + DMC | 23 (0.10) |
| 3 | DP + HTN | 565 (0.02) | DP + HTN | 228 (0.01) | METS + TU | 8 (0.02) | HTN + OB | 4 (0.02) | DM + HTN | 10 (0.04) |
| 4 | DP + PSY | 485 (0.02) | DM + DMC + HTN | 188 (0.01) | HTN + HY | 6 (0.02) | METS + TU | 3 (0.01) | DMC + HTN | 9 (0.04) |
| 5 | DP + NEU | 297 (0.01) | HTN + LYT | 183 (0.01) | HY + TU | 5 (0.01) | DP + DG + HTN + PSY | 3 (0.01) | DM + DMC + HTN + OB | 8 (0.04) |
| Ages: 60–74, (0.30), [n = 66282] | ||||||||||
| 44117 (0.67) | 16854 (0.25) | 337 (0.01) | 196 (<0.00) | 181 (<0.00) | ||||||
| 1 | DM + HTN | 1561 (0.04) | DM + HTN | 872 (0.06) | DM + HTN | 20 (0.06) | DM + HTN | 8 (0.04) | DM + DMC + HTN | 23 (0.13) |
| 2 | HTN + OB | 913 (0.02) | HTN + OB | 483 (0.03) | DP + HTN | 7 (0.02) | HTN + OB | 5 (0.02) | DM + HTN | 13 (0.07) |
| 3 | HTN + TU | 678 (0.02) | HTN + TU | 190 (0.01) | DM + DMC + HTN | 7 (0.02) | HTN + TU | 4 (0.02) | DMC + HTN | 11 (0.06) |
| 4 | DP + HTN | 450 (0.01) | DM + HTN + OB | 187 (0.01) | HTN + OB | 7 (0.02) | HTN + REN | 2 (0.01) | DMC + HTN + REN | 6 (0.03) |
| 5 | METS + TU | 398 (0.01) | DM + DMC + HTN + OB | 162 (0.01) | HTN + LYT | 6 (0.02) | HTN + OB + TU | 2 (0.01) | DM + DMC | 5 (0.02) |
| Ages: 75–88, (0.15), [n = 32924] | ||||||||||
| 25049 (0.76) | 5455 (0.17) | 151 (<0.00) | 57 (<0.00) | 38(<0.00) | ||||||
| 1 | DM + HTN | 831 (0.03) | DM + HTN | 337 (0.06) | DM + HTN | 8 (0.05) | CHF + HTN | 3 (0.05) | DMC + HTN | 3 (0.08) |
| 2 | HTN + NEU | 554 (0.02) | HTN + TU | 66 (0.01) | HTN + LIV | 3 (0.02) | DM + HTN | 1 (0.02) | DM + HTN | 3 (0.08) |
| 3 | HTN + TU | 535 (0.02) | HTN + NEU | 58 (0.01) | DM + HTN + REN | 3 (0.02) | NEU + TU | 1 (0.02) | HTN + HY | 2 (0.05) |
| 4 | HTN + HY | 259 (0.01) | HTN + OB | 47 (0.01) | DM + DMC | 2 (0.01) | LYT + NEU + PAR | 1 (0.02) | HTN + PER | 2 (0.05) |
| 5 | HTN + OB | 181 (0.01) | DM + HTN + TU | 43 (0.01) | HTN + PAR | 2 (0.01) | HTN + PAR | 1 (0.02) | HTN + REN | 1 (0.03) |
| Ages: 89–105 (0.03), [n = 7396] | ||||||||||
| 5540 (0.75) | 1203 (0.16) | 37 (<0.00) | 4 (<0.00) | 2 (<0.00) | ||||||
| 1 | HTN + NEU | 170 (0.03) | DM + HTN | 37 (0.03) | HTN + LYT + NEU | 2 (0.05) | HTN + MET | 1 (0.25) | ANE + CHF + HY + REN | 1 (0.05) |
| 2 | HTN + HY | 93 (0.02) | HTN + NEU | 17 (0.01) | DM + DMC | 2 (0.05) | HTN + LIV + REN + TU | 1 (0.25) | HTN + TU | 1 (0.05) |
| 3 | DM + HTN | 86 (0.02) | ANE + HTN | 9 (0.01) | PER + TU | 1 (0.03) | DM + HTN | 1 (0.25) | ||
| 4 | CHF + HTN | 85 (0.02) | HTN + OB | 9 (0.01) | HTN + LYT + REN | 1 (0.03) | HTN + NEU | 1 (0.25) | ||
| 5 | HTN + TU | 80 (0.01) | CHF + HTN | 8 (0.01) | HTN + LYT + NEU + REN + TU | 1 (0.03) | ||||
*ANE = anemia deficiency; BL = blood loss anemia; CHF = congestive heart failure; COA = coagulopathy; CP = chronic pulmonary disease; DP = depression; DM = uncomplicated diabetes; DMC = complicated diabetes; DG = drug abuse; HTN = complicated hypertension; HY = hypothyroidism; LIV = liver disease; LYT = fluid and electrolyte disorders; METS = metastatic cancer; NEU = neurological disorders; OB = obesity; PAR = paralysis; PER = peripheral vascular disorders; PSY = psychoses; REN = renal failure; TU = solid tumor without metastasis; VAL = valvular disease.
Among patients of all ages with two chronic conditions (Table 2), the most frequently occurring combination of chronic conditions was diabetes with hypertension in males (3267 [4%]) and hypertension with obesity in females (3788 [3%]). Among patients ages 18 to 30, the most frequently occurring combination of chronic conditions was depression with psychoses in both males (678 [11%]) and females (1182 [8%]). Among patients ages 31 to 44, the most frequently occurring combination of chronic conditions was hypertension with obesity in both males (502 [4%]) and females (1182 [4%]). Among patients ages 45 to 59, the most frequently occurring combination of chronic conditions was uncomplicated diabetes with hypertension in males (999 [4%]) and hypertension with obesity in females (1104 [4%]). Diabetes with hypertension was the most frequently occurring chronic condition combination in males and females ages 60 to 74 (1400 [5%] males and 1342 [4%] females) and males and females ages 75 to 88 (579 [4%] males and 615 [3%] females). Among patients ages 89 to 105, the most frequently occurring combination of chronic conditions was hypertension with neurological disorders in both males (64 [4%]) and females (144 [3%]).
Among all ages of patients with multimorbidity, uncomplicated diabetes with hypertension was the most frequently occurring combination of chronic conditions among Caucasian Americans (3615 [3%]), Asian Americans (56 [4%]), and American Indian and Alaskan Natives (24 [4%]) (Table 3). Hypertension with obesity was the most frequently occurring combination of chronic conditions among African American patients (2430 [4%]) of all ages. Among all ages of Native Hawaiian and other Pacific Islanders, diabetes (complicated and uncomplicated) with hypertension was the most frequently occurring chronic condition (56 [9%]).
Among patients with multimorbidity ages 18 to 30, depression with psychoses was the most frequently occurring combination of chronic conditions among Caucasian Americans (1124 [11%]), African Americans (475 [6%]), Asian Americans (17 [15%]), and American Indian and Alaskan Natives (4 [5%]) (Table 3). Anemia deficiency with blood loss anemia was the most frequently occurring combination of chronic conditions among Native Hawaiian and other Pacific Islanders in this age group (4 [11%]).
Among patients with multimorbidity ages 31 to 44, depression with psychoses was the most frequently occurring combination of chronic conditions among Caucasian Americans (822 [4%]) (Table 3). Hypertension with obesity was the most frequently occurring combination of chronic conditions among African Americans (823 [6%]) ages 31 to 44. Anemia deficiency with blood loss anemia was the most frequently occurring combination of chronic conditions among Asian Americans (20 [6%]) and American Indian and Alaskan Natives (8 [5%]). Uncomplicated diabetes combined with complicated diabetes was the most frequently occurring combination of chronic conditions among Native Hawaiian and other Pacific Islanders in this age group (19 [15%]).
Among patients with multimorbidity ages 45 to 59, hypertension with obesity was the most frequently occurring combination of chronic conditions among Caucasian Americans (898 [3%]) and African Americans (790 [5%]) (Table 3). Uncomplicated diabetes with hypertension was the most frequently occurring combination of chronic conditions among Asian Americans (22 [6%]) and American Indian and Alaskan Natives (9 [4%]) in this age group. Diabetes (complicated and uncomplicated) with hypertension was the most frequently occurring combination of chronic conditions among Native Hawaiian and other Pacific Islanders (23 [13%]) ages 45 to 59.
Among patients with multimorbidity ages 60 to 74, complicated diabetes with hypertension was the most frequently occurring chronic condition among Caucasian Americans (1561 [4%]), African Americans (872 [6%]), Asian Americans (20 [6%]), and American Indian and Alaskan Natives (8 [4%]) (Table 3). In this age group, diabetes (complicated and uncomplicated) with hypertension was the most frequently occurring chronic condition among Native Hawaiian and other Pacific Islanders (23 [13%]).
Among patients with multimorbidity ages 75 to 88, uncomplicated diabetes with hypertension was the most frequently occurring combination of chronic conditions among Caucasian Americans (831 [3%]), African Americans (337 [6%]), and Asian Americans (8 [5%]) (Table 3). Congestive heart failure with hypertension was the most frequently occurring combination of chronic conditions among American Indian and Alaskan Natives (3 [5%]) in this age group. Complicated diabetes with hypertension was the most frequently occurring combination of chronic conditions among Native Hawaiian and other Pacific Islanders (3 [8%]) ages 75 to 88.
Among patients with multimorbidity ages 89 to 105, hypertension with neurological disorders was the most frequently occurring combination of chronic conditions among Caucasian Americans (170 [3%]) and uncomplicated diabetes with hypertension among African Americans (37 [3%]) (Table 3). Among Asian Americans in this age group, hypertension with neurological disorders and fluid and electrolyte disorders was the most frequently occurring combination of chronic conditions (2 [5%]). Among American Indian and Alaskan Natives ages 89 to 105, hypertension with metastatic cancer was the most frequently occurring combination of chronic conditions (1 [25%]).
Table 4 reflects additional categories of race (i.e., other race, unknown race) and ethnicity. The category of “other race” represents patients of non-American nationality (e.g., of African descent, but not “African American,” of Asian descent but not “Asian American”). For all ages, uncomplicated diabetes with hypertension was the most frequently occurring combination of chronic conditions among patients of other race (263 [4%]) and Hispanic, LatinX, and Spanish ethnicity (248 [4%]). Depression with psychoses was the most frequently occurring combination of chronic conditions among all ages of patients of unknown race (508 [4%]).
Among patients with multimorbidity ages 18 to 30, anemia deficiency with blood loss anemia was the most frequently occurring combination of chronic conditions among patients of other race (138 [1%]) and those of Hispanic, LatinX, and Spanish ethnicity (134 [9%]) (Table 4). Depression with psychoses was the most frequently occurring combination of chronic conditions among patients with multimorbidity of unknown race in this age group (269 [15%]).
Among patients with multimorbidity ages 31 to 44, anemia deficiency with blood loss anemia was the most frequently occurring combination of chronic conditions among patients of other race (112 [5%]) and those of Hispanic, LatinX, and Spanish ethnicity (96 [5%]) patients with multimorbidity (Table 4). In the same age group, depression with psychoses was the most frequently occurring combination of chronic conditions among patients of unknown race (145 [7%]).
Among patients with multimorbidity ages 45 to 59, uncomplicated diabetes with hypertension was the most frequently occurring combination of chronic conditions among patients of other race (106 [6%]) and those of Hispanic, LatinX, and Spanish ethnicity (108 [7%]) (Table 4). Within the same age group, hypertension with obesity was the most frequently occurring combination of chronic conditions among patients of unknown race (130 [5%]).
Among patients with multimorbidity ages 60 to 74, uncomplicated diabetes with hypertension was the most frequently occurring combination of chronic conditions among patients of other race (103 [6%]), Hispanic, LatinX, and Spanish ethnicity (71 [7%]), and unknown race (196 [6%]) (Table 4).
Among patients with multimorbidity ages 75 to 88, uncomplicated diabetes with hypertension was the most frequently occurring combination of chronic conditions among patients of other race (24 [5%]), Hispanic, LatinX, and Spanish ethnicity (11 [3%]), and unknown race (75 [4%]) (Table 4).
Among patients with multimorbidity ages 89 to 105, uncomplicated diabetes with hypertension was the most frequently occurring combination of chronic conditions among patients of other race (4 [4%]) and those of Hispanic, LatinX, and Spanish ethnicity (2 [2%]) (Table 4). Among patients of unknown race in this age group, hypertension with neurological disorders was the most frequently occurring combination of chronic conditions (16 [3%]).
Discussion
The study characterized patterns of multimorbidity across patients. Subsequently, the study assessed the informatics capacity (technologies, data, processes, etc.) of a learning health system, using the AR-CDR as a use case. The study found multimorbidity was highest among patients ages 60 to 74, Caucasians, females, and Medicare payors. The largest numbers of chronic conditions occurred in the smallest numbers of patients with multimorbidity (i.e., 70,262 (31%) patients with two conditions, two (<1%) patients with 22 chronic conditions). Patients from racially underrepresented groups have been consistently shown to have the highest rates of mortality and have had lower rates of insurance coverage before becoming Medicare age-eligible.8–13 Age has been of consistent interest in monitoring the expansion of disease accumulation throughout the lifespan, 35 grounded in the accumulation of chronic conditions throughout the lifespan.
Broadly, the results revealed that the LHS’s captured data supported the characterization of multimorbidity across patients through the stratification of multimorbidity patient data among demographic variables (i.e., age, race, ethnicity, gender, and insurance). However, the study revealed several urgent needs (detailed longitudinal tracking of compounded diagnoses, additional data elements, etc.) to expand the LHS’s informatics capacity.
Differences in chronic disease patterns
Over 40 studies estimated the national prevalence of multimorbidity ranged from 13% in adults ages 18 and older to 95% in populations ages 65 and older.35,36 Broadly, the results were consistent with similar studies conducted between 1988 and 2018.35–37 However, significant differences in chronic disease patterns were identified. Importantly, the combinations of most frequently occurring conditions combinations differed from national estimates.38–40 More specifically, uncomplicated diabetes with hypertension was the most frequently occurring combination of chronic conditions identified among all patients with multimorbidity (6514 patients [6%]). Diabetes and hypertension were also largely represented in secondary and tertiary patterns that were identified. Data from the Behavioral Risk Factor Surveillance System (n = 450,462) estimated the combination of hyperlipidemia and hypertension as the most frequently occurring combination in Arkansas. 6 An analysis of data from the National Health Interview Survey (n = 166,126) estimated the most frequently occurring multimorbidity combinations were a dyad of arthritis with hypertension and the triad of arthritis with hypertension and diabetes. 2 A study of Medical Expenditure Panel Survey data (n = 24,870) found the most frequently occurring dyad was hypertension with hyperlipidemia and a triad of diabetes, hypertension, and hyperlipidemia. 39 A study of National Ambulatory Medical Care Survey data (n = 36,697) found the most frequent dyad was hypertension with hyperlipidemia and a triad of hypertension with hyperlipidemia and diabetes. 40 Within these national estimates, hyperlipidemia was a notable difference when compared against the actual disease occurrences identified in this study. Yet, collectively, these national estimates of occurrences (diabetes, hypertension, hyperlipidemia, etc.) have contributed to Arkansas’ reputation as a member of the “Stroke-belt” [States with high stroke mortality rates].40,41 Diabetes, hypertension, and hyperlipidemia are commonly co-occurring in patients,42,43 a consistently identified characteristic of many non-communicable, chronic diseases patterns with similar risk behaviors (e.g., nutrition, physical activity, and smoking habits). Yet, patterns of chronic disease remain much less predictable than communicable diseases which follow clearer patterns of spreading across populations through disease carrying agents. 44 Chronic disease patterns will remain unelucidated without future examinations of the risk factors (i.e., psycho-social, cultural, ethnic, and socioeconomic attributes of populations) that underpin chronic diseases accumulation . 44 Furthermore, clinical information systems must expand data collection efforts to include risk factor data. Patient assessments performed by clinical teams at the point-of-care can no longer continue to exist in isolation with linear foci on collecting physiological data (e.g., temperature, heart rate, glucose levels, and blood pressure), alone, largely due to our reliance on using population-level research to address risk factors. However, the amelioration of chronic diseases can more comprehensively be addressed by intersecting clinical and public health domains to cultivate informatics’ capacity to improve patient outcomes.
Cultivating informatics capacity in the LHS
Findings revealed an array of chronic condition combinations within multimorbidity. This emphasizes the need for healthcare systems to simultaneously provide care for both the diverse, routine care needs of multimorbidity (e.g., non-communicable diseases) that can be anticipated and facilitate the variability of unplanned care encounters that are needed during such times as large-scale, communicable disease outbreaks. 30 Complicatedly, medical care (e.g., clinical guidelines and therapeutics) has been traditionally siloed into single disease processes, not the complex interplay of multiple medical conditions [and multiple social conditions, for that matter]. 19 This has significantly limited the data that is currently captured. Historically, data elements are the primary support mechanisms for clinical research (i.e., Charlson Comorbidity Index, Elixhauser Score) and improvements in population health.45,46 Most significantly, this provides an opportunity for creating more structured, multimorbidity-centric data elements that are collected and collated in EHR systems. New data elements, fueled by clinical assessments, could include a dichotomous classification of each patient as “multimorbid.” Further, within EHR systems, there is a need for more enhanced processes of detailed, longitudinal tracking of initial chronic diagnoses and subsequent chronic conditions as they are compounded. For example, African American patients were more likely to have hypertension and obesity at an earlier age (i.e., 31–44) than their Caucasian American counterparts. However, the lack of multimorbidity data elements inhibited the use of the EHR to trigger flags when an African American patient crosses a multimorbidity age-related, risk threshold. These additional multimorbidity data elements could better position care systems to address health equity across the life span. Furthermore, additional data elements could prevent multimorbidity patients from converting to the highest cost tier, decreasing the overall cost of healthcare in the US.
Additional data elements would provide the infrastructure required to integrate recent advancements in informatics such as the use of clinical data registries.46,47 Clinical data registries serve as primary databases of aggregated, longitudinal health data (i.e., patient characteristics, treatment patterns, and clinical outcomes) related to specific conditions.46,48 Registries aggregate data from EHR systems at local, regional, and national levels. 49 First, the informatics infrastructure of existing clinical data registries focused on single conditions could be enhanced to support the extracting and sharing of data from multiple disease registries for use in multimorbidity research. In contrast, consolidated datasets cannot be easily obtained and aggregated from other sources, suggesting a need to formalize a registry for multimorbidity. Unfortunately, there are no known clinical data registries that explicitly target multimorbidity without being confined by the lens of single, chronic conditions (e.g., cancer, diabetes, and stroke).
Furthermore, the establishment of clinical data registries facilitates the adoption of emerging data standards for linking clinical data registries with EHR systems. 46 Data standards assist with automating the exchange and reuse of data between EHR systems and clinical data registries. 46 For example, the integration of the new Fast Healthcare Interoperability Resources (FHIR®) data standard would advance the meaning and format of new, structured data elements collected in EHR systems. 46 Integrating FHIR, in conjunction with new data elements and a new multimorbidity-centered clinical data registry could improve point-of-care feedback loops within LHS, providing real world evidence from real world data to clinical teams.47,49,50 Fueling feedback loops with these recent advances in informatics could reveal how patients are preforming, nationally, in the combination of single, chronic conditions that compose multimorbidity (e.g., HbA1c, lipid, and systolic/diastolic levels in diabetes, hyperlipidemia, and hypertension, respectively). 50 These advances provide a pathway for improving EHR utility to the LHS and respond to national calls for embedding data standards clinical research in informatics. 48 This maximizes the utilization of those with the highest spend in healthcare (i.e., 50% of healthcare spend is in the top 5% of multimorbidity patients), generating elasticity that could ensure stability of a health care system when balancing routine and critical care needs. 21 Further, understanding multimorbidity patients (and those that worsen) versus those that are static can provide insight into healthcare systems. Without more multimorbid-centric informatics infrastructure (e.g., data elements, standards, and registries), clinical data cannot be maximized for use in the clinical and population research that strengthens the LHS.
Limitations
Study data were generated from Arkansas’ only academic medical center, which provides care for patients throughout the entire state of Arkansas. However, this academic health center setting may be more diverse than smaller, non-academic health centers that provide care throughout the State. Findings may not be generalizable to the larger population of individuals living with multimorbidity in the region.
Conclusion
Learning health systems for multimorbidity have the capacity to characterize patterns of multimorbidity among an array of demographic groups (i.e., age, gender, race, and ethnicity) with ease. However, learning health systems are constrained by current technologies, data elements, and data-capturing processes. As a next step, more structured multimorbidity-centric, data elements must be created in EHR systems (i.e., dichotomous classifications of patients as “multimorbid,” longitudinal tracking of initial chronic disease diagnoses and subsequent chronic conditions as they compound). Finally, robust socio-technical system studies of clinical workflows are needed to assess the feasibility of integrating the collection of risk factor data elements (i.e., psycho-social, cultural, ethnic, and socioeconomic attributes of populations) into primary care encounters that patients have with healthcare systems. These approaches to advancing learning health systems for multimorbidity could substantially reduce the constraints of current technologies, data elements, and data-capturing processes. Without additional capacity for collecting and aggregating large-scale data, multimorbidity patients cannot benefit from the recent advancements in informatics (i.e., clinical data registries, emerging data standards) that are abundantly working to improve the care outcomes of patients with single chronic conditions.
Footnotes
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Translational Research Institute (TRI) [grant TR003107 and KL2 TR003108] through the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
ORCID iDs
Tremaine B Williams https://orcid.org/0000-0003-4902-3038
Maryam Garza https://orcid.org/0000-0002-2652-5935
References
- 1.Centers for Medicare and Medicaid Services . Multiple chronic conditions, https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Chronic-Conditions/CC_Main (2021, accessed 9 March 2021).
- 2.Zheng D, Loewenstein D, Christ S, et al. Multimorbidity patterns and their relationship to mortality in the US older adult population. PLOS One 2021; 16: 1–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Marengoni A, von Strauss E, Rizzuto D, et al. The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community-based, longitudinal study. J Intern Med 2009; 265: 288–295. [DOI] [PubMed] [Google Scholar]
- 4.Boersma P, Black L, Ward B. Prevalence of multiple chronic conditions among us adults, 2018. Prev Chron Dis 2020; 17: 106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Buttorff C, Ruder T, Bauman M. Multiple chronic conditions in the united states. RAND 2017; 1–27. [Google Scholar]
- 6.Newman D, Tong M, Levine E, et al. Prevalence of multiple chronic conditions by U.S. state and territory, 2017. PLOS One 2020; 15: e0239986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Mitchell E. Concentration of health expenditures in the U.S. civilian noninstitutionalized population, 2014. In: Statistical brief (medical expenditure panel survey (US)). Agency for Healthcare Research and Quality (US), 2016. [PubMed] [Google Scholar]
- 8.Angel R, Angel J, Hill T. Longer lives, sicker lives? Increased longevity and extended disability among Mexican-origin elders. J Gerontol 2015; 70: 639–649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Quiñones A, Botoseneanu A, Markwardt S, et al. Racial/ethnic differences in multimorbidity development and chronic disease accumulation for middle-aged adults. PLOS One 2019; 14: e0218462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Smedley B, Stith A, Nelson A. Institute of medicine (US) committee on understanding and eliminating racial and ethnic disparities in health care. In: Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, D.C: National Academies Press (US), 2003. [PubMed] [Google Scholar]
- 11.Chen J, Diamant A, Pourat N, et al. Racial/ethnic disparities in the use of preventive services among the elderly. Am J Prev Med 2005; 29: 388–395. [DOI] [PubMed] [Google Scholar]
- 12.DeNavas-Walt C, Proctor B, Smith J. Income, poverty, and health insurance coverage in the united states: 2012. Current Population Reports (P60-245). Suitland-Silver Hill, MD. US Census Bureau, 2013. Available: https://eric.ed.gov/?id=ED575469 [Google Scholar]
- 13.Sarnak D, Ryan J. How high-need patients experience the healthcare system in nine countries. Rep The Commonw Fund 2016; 1: 1–14. [PubMed] [Google Scholar]
- 14.Varmaghani M, Dehghani M, Heidari E, et al. Global prevalence of chronic obstructive pulmonary disease: Systematic review and meta-analysis. East Mediterr Health J 2019; 25: 47–57. [DOI] [PubMed] [Google Scholar]
- 15.Egede L. Effect of comorbid chronic diseases on prevalence and odds of depression in adults with diabetes. Psychosom Med 2005; 67: 46–51. [DOI] [PubMed] [Google Scholar]
- 16.Bertoni A, Hundley W, Massing M, et al. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 2004; 27: 699–703. [DOI] [PubMed] [Google Scholar]
- 17.Davis J, Penha J, Mbowe O, et al. Prevalence of single and multiple leading causes of death by race/ethnicity among us adults aged 60 to 79 years. Prev Chronic Dis 2017; 19: E101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Adamsen C, Schroeder S, LeMire S, et al. Education, income, and employment and prevalence of chronic disease among American Indian/Alaska Native elders. Prev Chronic Dis 2018; 15: E37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Vogeli C, Shields A, Lee T, et al. Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med 2007; 22: 391–395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Gijsen R, Hoeymans N, Schellevis F, et al. Causes and consequences of comorbidity: A review. J Clin Epidemiol 2001; 54: 661–674. [DOI] [PubMed] [Google Scholar]
- 21.Mitchell E. 2016.Concentration of health expenditures and selected characteristics of high spenders, U.S. civilian noninstitutionalized population. Report for Agency for Healthcare Research and Quality Medical Expenditure Panel Survey, 1 Feb 2019. Rockville, MD, [PubMed] [Google Scholar]
- 22.Nicholson K, Terry AL, Fortin M, et al. Prevalence, characteristics, and patterns of patients with multimorbidity in primary care: A retrospective cohort analysis in Canada. Br J Gen Pract 2019; 69: 647–656. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Jacobs EA, Ogedegbe O, Fihn SD. Elective care and health services research in the COVID-19 Era. JAMA Netw Open 2020; 3(11): e2025731. [DOI] [PubMed] [Google Scholar]
- 24.Whaley CM, Pera MF, Cantor J, et al. Changes in health services use among commercially insured us populations during the COVID-19 pandemic. JAMA Netw Open 2020; 3(11): e2024984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Govier DJ, Cohen-Cline H, Marsi K, et al. Differences in access to virtual and in-person primary care by race/ethnicity and community social vulnerability among adults diagnosed with COVID-19 in a large, multi-state health system. BMC Health Serv Res 2022; 22(1): 511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Roth SE, Govier DJ, Marsi K, et al. Differences in outpatient health care utilization 12 months after COVID-19 infection by race/ethnicity and community social vulnerability. Int J Environ Res Public Health 2022; 19(6): 3481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Schriger DL. Learning from the decrease in us emergency department visits in response to the coronavirus disease 2019 pandemic. JAMA Intern Med 2020; 180(10): 1334–1335. [DOI] [PubMed] [Google Scholar]
- 28.Jeffery MM, D'Onofrio G, Paek H, et al. Trends in emergency department visits and hospital admissions in health care systems in 5 states in the first months of the COVID-19 pandemic in the US. JAMA Intern Med 2020; 180(10): 1328–1333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Patzer RE, Fayanju OM, Kelz RR. Using health services research to address the unique challenges of the COVID-19 pandemic. JAMA Surg 2021; 156(10): 903–904. [DOI] [PubMed] [Google Scholar]
- 30.Blumenthal D, Fowler EJ, Abrams M, et al. Covid-19 - implications for the health care system. N Engl J Med 2020; 383(15): 1483–1488. [DOI] [PubMed] [Google Scholar]
- 31.AHRQ . About learning health systems, www.ahrq.gov/learning-health-systems/about.html (2021, accessed 29 November 2021).
- 32.Samal L, Fu HN, Camara DS, et al. Health information technology to improve care for people with multiple chronic conditions. Health Serv Res 2021; 56: 1006–1036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Baghal A, Zozus M, Al-Shukri S, et al. Factors associated with increased adoption of a research data warehouse. Stud Health Technol Inform 2019; 257: 31–35. [PubMed] [Google Scholar]
- 34.Greene SM, Reid RJ, Larson EB. Implementing the learning health system: from concept to action. Ann Intern Med 2012; 157: 207–210. [DOI] [PubMed] [Google Scholar]
- 35.King D, Xiang J, Pilkerton C. Multimorbidity trends in united states adults, 1988-2014. J Am Board Fam Med 2018; 31: 503–513. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Violan C, Foguet-Boreu Q, Flores-Mateo G, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One 2014; 9: e102149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Asogwa OA, Boateng D, Marzà-Florensa A, et al. Multimorbidity of non-communicable diseases in low-income and middle-income countries: a systematic review and meta-analysis. BMJ Open 2022; 12: e049133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Ward B, Schiller J. Prevalence of multiple chronic conditions among US adults: estimates from the national health interview survey, 2010. Prev Chronic Dis 2013; 10: E65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Machlin S, Soni A. Health care expenditures for adults with multiple treated chronic conditions: estimates from the medical expenditure panel survey, 2009. Prev Chronic Dis 2013; 10: E63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Ward B, Black L. State and regional prevalence of diagnosed multiple chronic conditions among adults aged ≥18 years - United States, 2014. Morb Mortal Wkly Rep 2016; 65: 735–738. [DOI] [PubMed] [Google Scholar]
- 41.Brooks DC, Schindler JL. Management of hyperlipidemia after stroke. Curr Treat Options Cardio Med 2019; 21: 93. [DOI] [PubMed] [Google Scholar]
- 42.Schroeder EB, Hanratty R, Beaty BL, et al. Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems. Circ. Cardiovasc Qual Outcomes 2012; 5: 645–653. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Paranjpe R, Chen H, Johnson ML, et al. Adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments among older patients. J Am Pharm Assoc 2022; 22: 1544–3191. [DOI] [PubMed] [Google Scholar]
- 44.Ackland M, Choi BC, Puska P. Rethinking the terms non-communicable disease and chronic disease. J Epidemiol Community Health 2003; 57: 838–839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Austin SR, Wong YN, Uzzo RG, et al. Why summary comorbidity measures such as the Charlson comorbidity index and elixhauser score work. Med Care 2015; 53: 65–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Garza MY, Rutherford MW, Adagarla B, et al. Evaluating site-level implementations of the HL7 FHIR standard to support esource data exchange in clinical research. Stud Health Technol Inform 2021; 281: 397–401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Richesson RL. Learning health systems, embedded research, and data standards-recommendations for healthcare system leaders. JAMIA Open 2020; 3: 488–491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Alger HM, Williams JH, Walchok JG, et al. Role of data registries in the time of COVID-19. Circ Cardiovasc Qual Outcomes 2020; 13: e006766. [DOI] [PubMed] [Google Scholar]
- 49.Morain SR, Kass NE, Grossmann C. What allows a health care system to become a learning health care system: Results from interviews with health system leaders. Learn Health Syst 2016; 1: e10015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002; 288: 1775–1779. [DOI] [PubMed] [Google Scholar]